PRRX1 and neoplasm: Prrx1 is also highly expressed in PDAC stroma and was reported to mediate CAF activation, leading to increased ECM deposition, improved tumor differentiation, fewer circulating tumor cells, and reduced metastasis (Feldmann et al., 2021).